Medical Care
Global Tumor Genomics Market Research Report 2024
- Apr 15, 24
- ID: 178234
- Pages: 92
- Figures: 196
- Views: 28
Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes.
The global Tumor Genomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tumor Genomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tumor Genomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tumor Genomics in Diagnostics and Monitoring is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tumor Genomics include Abbott Laboratories, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Fluidigm Corporation, General Electric Company, Illumina, Inc. and Merck KGaA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Genomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Genomics.
Report Scope
The Tumor Genomics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Genomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Genomics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Segment by Type
Assays and Kits
Instrument
Segment by Application
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Genomics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Tumor Genomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tumor Genomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tumor Genomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tumor Genomics in Diagnostics and Monitoring is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tumor Genomics include Abbott Laboratories, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Fluidigm Corporation, General Electric Company, Illumina, Inc. and Merck KGaA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Genomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Genomics.
Report Scope
The Tumor Genomics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Genomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Genomics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agilent Technologies, Inc
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
Illumina, Inc.
Merck KGaA
Myriad Genetics, Inc.
Pacific Biosciences of California, Inc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Segment by Type
Assays and Kits
Instrument
Segment by Application
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Genomics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Genomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Assays and Kits
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Tumor Genomics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics and Monitoring
1.3.3 Drug Discovery and Development
1.3.4 Biomarker Discovery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Genomics Market Perspective (2019-2030)
2.2 Tumor Genomics Growth Trends by Region
2.2.1 Global Tumor Genomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tumor Genomics Historic Market Size by Region (2019-2024)
2.2.3 Tumor Genomics Forecasted Market Size by Region (2025-2030)
2.3 Tumor Genomics Market Dynamics
2.3.1 Tumor Genomics Industry Trends
2.3.2 Tumor Genomics Market Drivers
2.3.3 Tumor Genomics Market Challenges
2.3.4 Tumor Genomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Genomics Players by Revenue
3.1.1 Global Top Tumor Genomics Players by Revenue (2019-2024)
3.1.2 Global Tumor Genomics Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Genomics Revenue
3.4 Global Tumor Genomics Market Concentration Ratio
3.4.1 Global Tumor Genomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Genomics Revenue in 2023
3.5 Tumor Genomics Key Players Head office and Area Served
3.6 Key Players Tumor Genomics Product Solution and Service
3.7 Date of Enter into Tumor Genomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Genomics Breakdown Data by Type
4.1 Global Tumor Genomics Historic Market Size by Type (2019-2024)
4.2 Global Tumor Genomics Forecasted Market Size by Type (2025-2030)
5 Tumor Genomics Breakdown Data by Application
5.1 Global Tumor Genomics Historic Market Size by Application (2019-2024)
5.2 Global Tumor Genomics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tumor Genomics Market Size (2019-2030)
6.2 North America Tumor Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tumor Genomics Market Size by Country (2019-2024)
6.4 North America Tumor Genomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Genomics Market Size (2019-2030)
7.2 Europe Tumor Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tumor Genomics Market Size by Country (2019-2024)
7.4 Europe Tumor Genomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Genomics Market Size (2019-2030)
8.2 Asia-Pacific Tumor Genomics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tumor Genomics Market Size by Region (2019-2024)
8.4 Asia-Pacific Tumor Genomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Genomics Market Size (2019-2030)
9.2 Latin America Tumor Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tumor Genomics Market Size by Country (2019-2024)
9.4 Latin America Tumor Genomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Genomics Market Size (2019-2030)
10.2 Middle East & Africa Tumor Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tumor Genomics Market Size by Country (2019-2024)
10.4 Middle East & Africa Tumor Genomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Tumor Genomics Introduction
11.1.4 Abbott Laboratories Revenue in Tumor Genomics Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies, Inc
11.2.1 Agilent Technologies, Inc Company Detail
11.2.2 Agilent Technologies, Inc Business Overview
11.2.3 Agilent Technologies, Inc Tumor Genomics Introduction
11.2.4 Agilent Technologies, Inc Revenue in Tumor Genomics Business (2019-2024)
11.2.5 Agilent Technologies, Inc Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Detail
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2019-2024)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Detail
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Tumor Genomics Introduction
11.4.4 Danaher Corporation Revenue in Tumor Genomics Business (2019-2024)
11.4.5 Danaher Corporation Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Detail
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Fluidigm Corporation
11.6.1 Fluidigm Corporation Company Detail
11.6.2 Fluidigm Corporation Business Overview
11.6.3 Fluidigm Corporation Tumor Genomics Introduction
11.6.4 Fluidigm Corporation Revenue in Tumor Genomics Business (2019-2024)
11.6.5 Fluidigm Corporation Recent Development
11.7 General Electric Company
11.7.1 General Electric Company Company Detail
11.7.2 General Electric Company Business Overview
11.7.3 General Electric Company Tumor Genomics Introduction
11.7.4 General Electric Company Revenue in Tumor Genomics Business (2019-2024)
11.7.5 General Electric Company Recent Development
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Detail
11.8.2 Illumina, Inc. Business Overview
11.8.3 Illumina, Inc. Tumor Genomics Introduction
11.8.4 Illumina, Inc. Revenue in Tumor Genomics Business (2019-2024)
11.8.5 Illumina, Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Tumor Genomics Introduction
11.9.4 Merck KGaA Revenue in Tumor Genomics Business (2019-2024)
11.9.5 Merck KGaA Recent Development
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Detail
11.10.2 Myriad Genetics, Inc. Business Overview
11.10.3 Myriad Genetics, Inc. Tumor Genomics Introduction
11.10.4 Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2019-2024)
11.10.5 Myriad Genetics, Inc. Recent Development
11.11 Pacific Biosciences of California, Inc.
11.11.1 Pacific Biosciences of California, Inc. Company Detail
11.11.2 Pacific Biosciences of California, Inc. Business Overview
11.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Introduction
11.11.4 Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2019-2024)
11.11.5 Pacific Biosciences of California, Inc. Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Detail
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Tumor Genomics Introduction
11.12.4 PerkinElmer Revenue in Tumor Genomics Business (2019-2024)
11.12.5 PerkinElmer Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Detail
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Tumor Genomics Introduction
11.13.4 QIAGEN Revenue in Tumor Genomics Business (2019-2024)
11.13.5 QIAGEN Recent Development
11.14 Siemens Healthineers AG
11.14.1 Siemens Healthineers AG Company Detail
11.14.2 Siemens Healthineers AG Business Overview
11.14.3 Siemens Healthineers AG Tumor Genomics Introduction
11.14.4 Siemens Healthineers AG Revenue in Tumor Genomics Business (2019-2024)
11.14.5 Siemens Healthineers AG Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Detail
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2019-2024)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Genomics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Assays and Kits
1.2.3 Instrument
1.3 Market by Application
1.3.1 Global Tumor Genomics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics and Monitoring
1.3.3 Drug Discovery and Development
1.3.4 Biomarker Discovery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Genomics Market Perspective (2019-2030)
2.2 Tumor Genomics Growth Trends by Region
2.2.1 Global Tumor Genomics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tumor Genomics Historic Market Size by Region (2019-2024)
2.2.3 Tumor Genomics Forecasted Market Size by Region (2025-2030)
2.3 Tumor Genomics Market Dynamics
2.3.1 Tumor Genomics Industry Trends
2.3.2 Tumor Genomics Market Drivers
2.3.3 Tumor Genomics Market Challenges
2.3.4 Tumor Genomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Genomics Players by Revenue
3.1.1 Global Top Tumor Genomics Players by Revenue (2019-2024)
3.1.2 Global Tumor Genomics Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Genomics Revenue
3.4 Global Tumor Genomics Market Concentration Ratio
3.4.1 Global Tumor Genomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Genomics Revenue in 2023
3.5 Tumor Genomics Key Players Head office and Area Served
3.6 Key Players Tumor Genomics Product Solution and Service
3.7 Date of Enter into Tumor Genomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Genomics Breakdown Data by Type
4.1 Global Tumor Genomics Historic Market Size by Type (2019-2024)
4.2 Global Tumor Genomics Forecasted Market Size by Type (2025-2030)
5 Tumor Genomics Breakdown Data by Application
5.1 Global Tumor Genomics Historic Market Size by Application (2019-2024)
5.2 Global Tumor Genomics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tumor Genomics Market Size (2019-2030)
6.2 North America Tumor Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tumor Genomics Market Size by Country (2019-2024)
6.4 North America Tumor Genomics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Genomics Market Size (2019-2030)
7.2 Europe Tumor Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tumor Genomics Market Size by Country (2019-2024)
7.4 Europe Tumor Genomics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Genomics Market Size (2019-2030)
8.2 Asia-Pacific Tumor Genomics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tumor Genomics Market Size by Region (2019-2024)
8.4 Asia-Pacific Tumor Genomics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Genomics Market Size (2019-2030)
9.2 Latin America Tumor Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tumor Genomics Market Size by Country (2019-2024)
9.4 Latin America Tumor Genomics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Genomics Market Size (2019-2030)
10.2 Middle East & Africa Tumor Genomics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tumor Genomics Market Size by Country (2019-2024)
10.4 Middle East & Africa Tumor Genomics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Tumor Genomics Introduction
11.1.4 Abbott Laboratories Revenue in Tumor Genomics Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies, Inc
11.2.1 Agilent Technologies, Inc Company Detail
11.2.2 Agilent Technologies, Inc Business Overview
11.2.3 Agilent Technologies, Inc Tumor Genomics Introduction
11.2.4 Agilent Technologies, Inc Revenue in Tumor Genomics Business (2019-2024)
11.2.5 Agilent Technologies, Inc Recent Development
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Bio-Rad Laboratories, Inc. Company Detail
11.3.2 Bio-Rad Laboratories, Inc. Business Overview
11.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Introduction
11.3.4 Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2019-2024)
11.3.5 Bio-Rad Laboratories, Inc. Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Detail
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Tumor Genomics Introduction
11.4.4 Danaher Corporation Revenue in Tumor Genomics Business (2019-2024)
11.4.5 Danaher Corporation Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Detail
11.5.2 F. Hoffmann-La Roche Ltd Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Introduction
11.5.4 F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 Fluidigm Corporation
11.6.1 Fluidigm Corporation Company Detail
11.6.2 Fluidigm Corporation Business Overview
11.6.3 Fluidigm Corporation Tumor Genomics Introduction
11.6.4 Fluidigm Corporation Revenue in Tumor Genomics Business (2019-2024)
11.6.5 Fluidigm Corporation Recent Development
11.7 General Electric Company
11.7.1 General Electric Company Company Detail
11.7.2 General Electric Company Business Overview
11.7.3 General Electric Company Tumor Genomics Introduction
11.7.4 General Electric Company Revenue in Tumor Genomics Business (2019-2024)
11.7.5 General Electric Company Recent Development
11.8 Illumina, Inc.
11.8.1 Illumina, Inc. Company Detail
11.8.2 Illumina, Inc. Business Overview
11.8.3 Illumina, Inc. Tumor Genomics Introduction
11.8.4 Illumina, Inc. Revenue in Tumor Genomics Business (2019-2024)
11.8.5 Illumina, Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Tumor Genomics Introduction
11.9.4 Merck KGaA Revenue in Tumor Genomics Business (2019-2024)
11.9.5 Merck KGaA Recent Development
11.10 Myriad Genetics, Inc.
11.10.1 Myriad Genetics, Inc. Company Detail
11.10.2 Myriad Genetics, Inc. Business Overview
11.10.3 Myriad Genetics, Inc. Tumor Genomics Introduction
11.10.4 Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2019-2024)
11.10.5 Myriad Genetics, Inc. Recent Development
11.11 Pacific Biosciences of California, Inc.
11.11.1 Pacific Biosciences of California, Inc. Company Detail
11.11.2 Pacific Biosciences of California, Inc. Business Overview
11.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Introduction
11.11.4 Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2019-2024)
11.11.5 Pacific Biosciences of California, Inc. Recent Development
11.12 PerkinElmer
11.12.1 PerkinElmer Company Detail
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Tumor Genomics Introduction
11.12.4 PerkinElmer Revenue in Tumor Genomics Business (2019-2024)
11.12.5 PerkinElmer Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Detail
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Tumor Genomics Introduction
11.13.4 QIAGEN Revenue in Tumor Genomics Business (2019-2024)
11.13.5 QIAGEN Recent Development
11.14 Siemens Healthineers AG
11.14.1 Siemens Healthineers AG Company Detail
11.14.2 Siemens Healthineers AG Business Overview
11.14.3 Siemens Healthineers AG Tumor Genomics Introduction
11.14.4 Siemens Healthineers AG Revenue in Tumor Genomics Business (2019-2024)
11.14.5 Siemens Healthineers AG Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Detail
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2019-2024)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Tumor Genomics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Assays and Kits
Table 3. Key Players of Instrument
Table 4. Global Tumor Genomics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Tumor Genomics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Tumor Genomics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Tumor Genomics Market Share by Region (2019-2024)
Table 8. Global Tumor Genomics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Tumor Genomics Market Share by Region (2025-2030)
Table 10. Tumor Genomics Market Trends
Table 11. Tumor Genomics Market Drivers
Table 12. Tumor Genomics Market Challenges
Table 13. Tumor Genomics Market Restraints
Table 14. Global Tumor Genomics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Tumor Genomics Market Share by Players (2019-2024)
Table 16. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2023)
Table 17. Ranking of Global Top Tumor Genomics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Tumor Genomics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tumor Genomics Product Solution and Service
Table 21. Date of Enter into Tumor Genomics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor Genomics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Tumor Genomics Revenue Market Share by Type (2019-2024)
Table 25. Global Tumor Genomics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Tumor Genomics Revenue Market Share by Type (2025-2030)
Table 27. Global Tumor Genomics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Tumor Genomics Revenue Market Share by Application (2019-2024)
Table 29. Global Tumor Genomics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Tumor Genomics Revenue Market Share by Application (2025-2030)
Table 31. North America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Tumor Genomics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Tumor Genomics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Tumor Genomics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Tumor Genomics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Tumor Genomics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Tumor Genomics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Tumor Genomics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Tumor Genomics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Tumor Genomics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Tumor Genomics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Tumor Genomics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Tumor Genomics Product
Table 49. Abbott Laboratories Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Agilent Technologies, Inc Company Detail
Table 52. Agilent Technologies, Inc Business Overview
Table 53. Agilent Technologies, Inc Tumor Genomics Product
Table 54. Agilent Technologies, Inc Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 55. Agilent Technologies, Inc Recent Development
Table 56. Bio-Rad Laboratories, Inc. Company Detail
Table 57. Bio-Rad Laboratories, Inc. Business Overview
Table 58. Bio-Rad Laboratories, Inc. Tumor Genomics Product
Table 59. Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 60. Bio-Rad Laboratories, Inc. Recent Development
Table 61. Danaher Corporation Company Detail
Table 62. Danaher Corporation Business Overview
Table 63. Danaher Corporation Tumor Genomics Product
Table 64. Danaher Corporation Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 65. Danaher Corporation Recent Development
Table 66. F. Hoffmann-La Roche Ltd Company Detail
Table 67. F. Hoffmann-La Roche Ltd Business Overview
Table 68. F. Hoffmann-La Roche Ltd Tumor Genomics Product
Table 69. F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 70. F. Hoffmann-La Roche Ltd Recent Development
Table 71. Fluidigm Corporation Company Detail
Table 72. Fluidigm Corporation Business Overview
Table 73. Fluidigm Corporation Tumor Genomics Product
Table 74. Fluidigm Corporation Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 75. Fluidigm Corporation Recent Development
Table 76. General Electric Company Company Detail
Table 77. General Electric Company Business Overview
Table 78. General Electric Company Tumor Genomics Product
Table 79. General Electric Company Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 80. General Electric Company Recent Development
Table 81. Illumina, Inc. Company Detail
Table 82. Illumina, Inc. Business Overview
Table 83. Illumina, Inc. Tumor Genomics Product
Table 84. Illumina, Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 85. Illumina, Inc. Recent Development
Table 86. Merck KGaA Company Detail
Table 87. Merck KGaA Business Overview
Table 88. Merck KGaA Tumor Genomics Product
Table 89. Merck KGaA Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 90. Merck KGaA Recent Development
Table 91. Myriad Genetics, Inc. Company Detail
Table 92. Myriad Genetics, Inc. Business Overview
Table 93. Myriad Genetics, Inc. Tumor Genomics Product
Table 94. Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 95. Myriad Genetics, Inc. Recent Development
Table 96. Pacific Biosciences of California, Inc. Company Detail
Table 97. Pacific Biosciences of California, Inc. Business Overview
Table 98. Pacific Biosciences of California, Inc. Tumor Genomics Product
Table 99. Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 100. Pacific Biosciences of California, Inc. Recent Development
Table 101. PerkinElmer Company Detail
Table 102. PerkinElmer Business Overview
Table 103. PerkinElmer Tumor Genomics Product
Table 104. PerkinElmer Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 105. PerkinElmer Recent Development
Table 106. QIAGEN Company Detail
Table 107. QIAGEN Business Overview
Table 108. QIAGEN Tumor Genomics Product
Table 109. QIAGEN Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 110. QIAGEN Recent Development
Table 111. Siemens Healthineers AG Company Detail
Table 112. Siemens Healthineers AG Business Overview
Table 113. Siemens Healthineers AG Tumor Genomics Product
Table 114. Siemens Healthineers AG Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 115. Siemens Healthineers AG Recent Development
Table 116. Thermo Fisher Scientific Inc. Company Detail
Table 117. Thermo Fisher Scientific Inc. Business Overview
Table 118. Thermo Fisher Scientific Inc. Tumor Genomics Product
Table 119. Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 120. Thermo Fisher Scientific Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Genomics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Tumor Genomics Market Share by Type: 2023 VS 2030
Figure 3. Assays and Kits Features
Figure 4. Instrument Features
Figure 5. Global Tumor Genomics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Tumor Genomics Market Share by Application: 2023 VS 2030
Figure 7. Diagnostics and Monitoring Case Studies
Figure 8. Drug Discovery and Development Case Studies
Figure 9. Biomarker Discovery Case Studies
Figure 10. Tumor Genomics Report Years Considered
Figure 11. Global Tumor Genomics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Tumor Genomics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Tumor Genomics Market Share by Region: 2023 VS 2030
Figure 14. Global Tumor Genomics Market Share by Players in 2023
Figure 15. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Tumor Genomics Revenue in 2023
Figure 17. North America Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Tumor Genomics Market Share by Country (2019-2030)
Figure 19. United States Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Tumor Genomics Market Share by Country (2019-2030)
Figure 23. Germany Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Tumor Genomics Market Share by Region (2019-2030)
Figure 31. China Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Tumor Genomics Market Share by Country (2019-2030)
Figure 39. Mexico Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Tumor Genomics Market Share by Country (2019-2030)
Figure 43. Turkey Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 46. Agilent Technologies, Inc Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 47. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 48. Danaher Corporation Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 49. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 50. Fluidigm Corporation Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 51. General Electric Company Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 52. Illumina, Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 53. Merck KGaA Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 54. Myriad Genetics, Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 55. Pacific Biosciences of California, Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 56. PerkinElmer Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 57. QIAGEN Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 58. Siemens Healthineers AG Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 59. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Tumor Genomics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Assays and Kits
Table 3. Key Players of Instrument
Table 4. Global Tumor Genomics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Tumor Genomics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Tumor Genomics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Tumor Genomics Market Share by Region (2019-2024)
Table 8. Global Tumor Genomics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Tumor Genomics Market Share by Region (2025-2030)
Table 10. Tumor Genomics Market Trends
Table 11. Tumor Genomics Market Drivers
Table 12. Tumor Genomics Market Challenges
Table 13. Tumor Genomics Market Restraints
Table 14. Global Tumor Genomics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Tumor Genomics Market Share by Players (2019-2024)
Table 16. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2023)
Table 17. Ranking of Global Top Tumor Genomics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Tumor Genomics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tumor Genomics Product Solution and Service
Table 21. Date of Enter into Tumor Genomics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor Genomics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Tumor Genomics Revenue Market Share by Type (2019-2024)
Table 25. Global Tumor Genomics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Tumor Genomics Revenue Market Share by Type (2025-2030)
Table 27. Global Tumor Genomics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Tumor Genomics Revenue Market Share by Application (2019-2024)
Table 29. Global Tumor Genomics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Tumor Genomics Revenue Market Share by Application (2025-2030)
Table 31. North America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Tumor Genomics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Tumor Genomics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Tumor Genomics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Tumor Genomics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Tumor Genomics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Tumor Genomics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Tumor Genomics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Tumor Genomics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Tumor Genomics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Tumor Genomics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Tumor Genomics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Tumor Genomics Product
Table 49. Abbott Laboratories Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Agilent Technologies, Inc Company Detail
Table 52. Agilent Technologies, Inc Business Overview
Table 53. Agilent Technologies, Inc Tumor Genomics Product
Table 54. Agilent Technologies, Inc Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 55. Agilent Technologies, Inc Recent Development
Table 56. Bio-Rad Laboratories, Inc. Company Detail
Table 57. Bio-Rad Laboratories, Inc. Business Overview
Table 58. Bio-Rad Laboratories, Inc. Tumor Genomics Product
Table 59. Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 60. Bio-Rad Laboratories, Inc. Recent Development
Table 61. Danaher Corporation Company Detail
Table 62. Danaher Corporation Business Overview
Table 63. Danaher Corporation Tumor Genomics Product
Table 64. Danaher Corporation Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 65. Danaher Corporation Recent Development
Table 66. F. Hoffmann-La Roche Ltd Company Detail
Table 67. F. Hoffmann-La Roche Ltd Business Overview
Table 68. F. Hoffmann-La Roche Ltd Tumor Genomics Product
Table 69. F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 70. F. Hoffmann-La Roche Ltd Recent Development
Table 71. Fluidigm Corporation Company Detail
Table 72. Fluidigm Corporation Business Overview
Table 73. Fluidigm Corporation Tumor Genomics Product
Table 74. Fluidigm Corporation Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 75. Fluidigm Corporation Recent Development
Table 76. General Electric Company Company Detail
Table 77. General Electric Company Business Overview
Table 78. General Electric Company Tumor Genomics Product
Table 79. General Electric Company Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 80. General Electric Company Recent Development
Table 81. Illumina, Inc. Company Detail
Table 82. Illumina, Inc. Business Overview
Table 83. Illumina, Inc. Tumor Genomics Product
Table 84. Illumina, Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 85. Illumina, Inc. Recent Development
Table 86. Merck KGaA Company Detail
Table 87. Merck KGaA Business Overview
Table 88. Merck KGaA Tumor Genomics Product
Table 89. Merck KGaA Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 90. Merck KGaA Recent Development
Table 91. Myriad Genetics, Inc. Company Detail
Table 92. Myriad Genetics, Inc. Business Overview
Table 93. Myriad Genetics, Inc. Tumor Genomics Product
Table 94. Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 95. Myriad Genetics, Inc. Recent Development
Table 96. Pacific Biosciences of California, Inc. Company Detail
Table 97. Pacific Biosciences of California, Inc. Business Overview
Table 98. Pacific Biosciences of California, Inc. Tumor Genomics Product
Table 99. Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 100. Pacific Biosciences of California, Inc. Recent Development
Table 101. PerkinElmer Company Detail
Table 102. PerkinElmer Business Overview
Table 103. PerkinElmer Tumor Genomics Product
Table 104. PerkinElmer Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 105. PerkinElmer Recent Development
Table 106. QIAGEN Company Detail
Table 107. QIAGEN Business Overview
Table 108. QIAGEN Tumor Genomics Product
Table 109. QIAGEN Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 110. QIAGEN Recent Development
Table 111. Siemens Healthineers AG Company Detail
Table 112. Siemens Healthineers AG Business Overview
Table 113. Siemens Healthineers AG Tumor Genomics Product
Table 114. Siemens Healthineers AG Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 115. Siemens Healthineers AG Recent Development
Table 116. Thermo Fisher Scientific Inc. Company Detail
Table 117. Thermo Fisher Scientific Inc. Business Overview
Table 118. Thermo Fisher Scientific Inc. Tumor Genomics Product
Table 119. Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2019-2024) & (US$ Million)
Table 120. Thermo Fisher Scientific Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Genomics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Tumor Genomics Market Share by Type: 2023 VS 2030
Figure 3. Assays and Kits Features
Figure 4. Instrument Features
Figure 5. Global Tumor Genomics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Tumor Genomics Market Share by Application: 2023 VS 2030
Figure 7. Diagnostics and Monitoring Case Studies
Figure 8. Drug Discovery and Development Case Studies
Figure 9. Biomarker Discovery Case Studies
Figure 10. Tumor Genomics Report Years Considered
Figure 11. Global Tumor Genomics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Tumor Genomics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Tumor Genomics Market Share by Region: 2023 VS 2030
Figure 14. Global Tumor Genomics Market Share by Players in 2023
Figure 15. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Tumor Genomics Revenue in 2023
Figure 17. North America Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Tumor Genomics Market Share by Country (2019-2030)
Figure 19. United States Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Tumor Genomics Market Share by Country (2019-2030)
Figure 23. Germany Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Tumor Genomics Market Share by Region (2019-2030)
Figure 31. China Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Tumor Genomics Market Share by Country (2019-2030)
Figure 39. Mexico Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Tumor Genomics Market Share by Country (2019-2030)
Figure 43. Turkey Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Tumor Genomics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 46. Agilent Technologies, Inc Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 47. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 48. Danaher Corporation Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 49. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 50. Fluidigm Corporation Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 51. General Electric Company Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 52. Illumina, Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 53. Merck KGaA Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 54. Myriad Genetics, Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 55. Pacific Biosciences of California, Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 56. PerkinElmer Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 57. QIAGEN Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 58. Siemens Healthineers AG Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 59. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tumor Genomics Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232